Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Cerilliant
Medtronic
Mallinckrodt
Teva
Fish and Richardson
UBS
Deloitte
Accenture
Citi

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021321

« Back to Dashboard

NDA 021321 describes EXTRANEAL, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the EXTRANEAL profile page.

The generic ingredient in EXTRANEAL is icodextrin. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the icodextrin profile page.
Summary for 021321
Tradename:EXTRANEAL
Applicant:Baxter Hlthcare
Ingredient:icodextrin
Patents:2
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021321
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321 NDA Baxter Healthcare Corporation 0941-0679 0941-0679-53 2500 mL in 1 BAG (0941-0679-53)
EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321 NDA Baxter Healthcare Corporation 0941-0679 0941-0679-06 2000 mL in 1 BAG (0941-0679-06)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAPERITONEALStrength7.5GM/100ML
Approval Date:Dec 20, 2002TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Jun 20, 2017Product Flag?Substance Flag?Delist Request?
Patented Use:PERITONEAL DIALYSIS SOLUTION
Patent:➤ SubscribePatent Expiration:Jun 19, 2018Product Flag?Substance Flag?Delist Request?
Patented Use:PERITONEAL DIALYSIS SOLUTION

Expired US Patents for NDA 021321

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 ➤ Subscribe ➤ Subscribe
Baxter Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 ➤ Subscribe ➤ Subscribe
Baxter Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
AstraZeneca
Baxter
Novartis
QuintilesIMS
Fish and Richardson
Chubb
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot